Reply to marx et al

Allan R. Tunkel*, Rodrigo Hasbun, Adarsh Bhimraj, Karin Byers, Sheldon L. Kaplan, W. Michael Scheld, Diederik Van De Beek, Thomas P Bleck, Joseph R. Zunt

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)1429-1430
Number of pages2
JournalClinical Infectious Diseases
Volume65
Issue number8
DOIs
StatePublished - Oct 1 2017

Funding

ports receiving personal fees from UpToDate, Elsevier, the American College of Physicians, and Merck, outside the submitted work. R. H. reports receiving personal fees from Biomerieux, The Medicines Company, Pfizer, Biofire, and Merck, outside the submitted work. S. L. K. reports receiving institutional grant support from Pfizer, Forest Laboratories, and Merck/Cubist, outside the submitted work. W. M. S. reports receiving grants from the National Institutes of Health, Pfizer, and Wyeth, outside the submitted work. D. v. d. B. reports receiving grants from the Netherlands Organization for Health Research and Development, the Netherlands Scientific Organization, the European Research Council, FP-7, Horizon 2020, and Omeros, and other support from GlaxoSmithKline, outside the submitted work. T. P. B. reports receiving grant support from Zoll, Sage, and Edge, outside the submitted work. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this